141 related articles for article (PubMed ID: 32787344)
1. Use of palliative chemotherapy near the end of life: a retrospective cohort study.
Zhang Z; Chen ML; Gu XL; Cheng WW
Ann Palliat Med; 2020 Sep; 9(5):2809-2816. PubMed ID: 32787344
[TBL] [Abstract][Full Text] [Related]
2. Palliative Chemotherapy Near the End of Life in Oncology Patients.
Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy and targeted therapy near the end of life affects aggressiveness of palliative care.
Zhang Z; Chen ML; Liu MH; Cheng WW
Ann Palliat Med; 2021 Mar; 10(3):2917-2925. PubMed ID: 33549022
[TBL] [Abstract][Full Text] [Related]
4. Palliative Chemotherapy Affects Aggressiveness of End-of-Life Care.
Wu CC; Hsu TW; Chang CM; Lee CH; Huang CY; Lee CC
Oncologist; 2016 Jun; 21(6):771-7. PubMed ID: 27091417
[TBL] [Abstract][Full Text] [Related]
5. End-of-life chemotherapy use at a Finnish university hospital: a retrospective cohort study.
Rautakorpi LK; Seyednasrollah F; Mäkelä JM; Hirvonen OM; Laitinen T; Elo LL; Jyrkkiö SM
Acta Oncol; 2017 Oct; 56(10):1272-1276. PubMed ID: 28562152
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.
Sheng J; Zhang YX; He XB; Fang WF; Yang YP; Lin GN; Wu X; Li N; Zhang J; Zhai LZ; Zhao YY; Huang Y; Zhou NN; Zhao HY; Zhang L
Oncologist; 2017 Jan; 22(1):53-60. PubMed ID: 27789776
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy use at the end of life. A retrospective single centre experience analysis.
Andreis F; Rizzi A; Rota L; Meriggi F; Mazzocchi M; Zaniboni A
Tumori; 2011; 97(1):30-4. PubMed ID: 21528660
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.
Lapeyre-Prost A; Perkins G; Vallee M; Pozet A; Tougeron D; Maillet M; Locher C; Dreanic J; Legoux JL; Lièvre A; Lecaille C; Sabate JM; Mary F; Bonnetain F; Jaulmes-Bouillot H; Behal F; Landi B; Taieb J
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101709. PubMed ID: 33930588
[TBL] [Abstract][Full Text] [Related]
9. Use of chemotherapy near the end of life: what factors matter?
Rochigneux P; Raoul JL; Beaussant Y; Aubry R; Goldwasser F; Tournigand C; Morin L
Ann Oncol; 2017 Apr; 28(4):809-817. PubMed ID: 27993817
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy at the End of Life.
Urvay S; Civelek B; Özaslan E; Sürel AA
J Palliat Care; 2021 Apr; 36(2):73-77. PubMed ID: 32762320
[TBL] [Abstract][Full Text] [Related]
11. Trends in treatment during the last stages of life in end-stage gynecologic cancer patients who received active palliative chemotherapy: a comparative analysis of 10-year data in a single institution.
Jang TK; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
BMC Palliat Care; 2018 Aug; 17(1):99. PubMed ID: 30086748
[TBL] [Abstract][Full Text] [Related]
12. End-of-life Care Among Gynecological Oncology Patients in a Single Institute in Israel.
Shapiro S; Lavie O; Schmidt M; Ben Arya E; Dagash J; Yosipovich A; Segev Y
Isr Med Assoc J; 2021 Sep; 23(9):556-562. PubMed ID: 34472230
[TBL] [Abstract][Full Text] [Related]
13. Effect of integrated palliative care on the quality of end-of-life care: retrospective analysis of 521 cancer patients.
Colombet I; Montheil V; Durand JP; Gillaizeau F; Niarra R; Jaeger C; Alexandre J; Goldwasser F; Vinant P
BMJ Support Palliat Care; 2012 Sep; 2(3):239-47. PubMed ID: 24654196
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy during the last 30 days of life and the role of palliative care referral, a single center experience.
Woldie I; Elfiki T; Kulkarni S; Springer C; McArthur E; Freeman N
BMC Palliat Care; 2022 Feb; 21(1):20. PubMed ID: 35125092
[TBL] [Abstract][Full Text] [Related]
15. Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review.
Bükki J; Scherbel J; Stiel S; Klein C; Meidenbauer N; Ostgathe C
Support Care Cancer; 2013 Jun; 21(6):1743-50. PubMed ID: 23344656
[TBL] [Abstract][Full Text] [Related]
16. A prospective cohort study assessing aggressive interventions at the end-of-life among patients with solid metastatic cancer.
Malhotra C; Bundoc F; Chaudhry I; Teo I; Ozdemir S; Finkelstein E;
BMC Palliat Care; 2022 May; 21(1):73. PubMed ID: 35578270
[TBL] [Abstract][Full Text] [Related]
17. Timing of palliative care referral and aggressive cancer care toward the end-of-life in pancreatic cancer: a retrospective, single-center observational study.
Michael N; Beale G; O'Callaghan C; Melia A; DeSilva W; Costa D; Kissane D; Shapiro J; Hiscock R
BMC Palliat Care; 2019 Jan; 18(1):13. PubMed ID: 30691417
[TBL] [Abstract][Full Text] [Related]
18. End-of-life decision-making of terminally ill cancer patients in a tertiary cancer center in Shanghai, China.
Gu X; Chen M; Liu M; Zhang Z; Cheng W
Support Care Cancer; 2016 May; 24(5):2209-2215. PubMed ID: 26567116
[TBL] [Abstract][Full Text] [Related]
19. Quality of end-of-life care of advanced cancer patients in mainland China-a retrospective cohort of 441 hospital-death in a public funded comprehensive hospital.
Li JS; Lam TC; Jing HM; Chen X; Cao MY; Huang C; Yang L; Xu ZY; Jiang Y; Li SS; Chen F; Han Y; Zhang YS; Lam KO; Lee AWM
Ann Palliat Med; 2020 Nov; 9(6):4514-4521. PubMed ID: 32692211
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death.
Enzinger AC; Zhang B; Weeks JC; Prigerson HG
J Pain Symptom Manage; 2014 Jun; 47(6):1078-90. PubMed ID: 24099894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
